TOMM20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.004600E-01
Normal-vs-Stage2
3.088800E-01
Normal-vs-Stage3
9.941000E-01
Normal-vs-Stage4
8.418100E-02
Stage1-vs-Stage2
5.292600E-01
Stage1-vs-Stage3
3.018000E-01
Stage1-vs-Stage4
4.944000E-01
Stage2-vs-Stage3
2.481600E-01
Stage2-vs-Stage4
1.632460E-02
Stage3-vs-Stage4
7.782000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.299000E-01
Normal-vs-AfricanAmerican
1.104210E-02
Normal-vs-Asian
2.990200E-01
Caucasian-vs-AfricanAmerican
2.174400E-01
Caucasian-vs-Asian
8.546400E-01
AfricanAmerican-vs-Asian
4.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.865200E-01
Normal-vs-Female
3.173000E-01
Male-vs-Female
1.034790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.792800E-01
Normal-vs-Age(41-60Yrs)
1.804420E-01
Normal-vs-Age(61-80Yrs)
3.686200E-01
Normal-vs-Age(81-100Yrs)
2.295600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.880000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.497400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.720790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.636200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.075200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.570400E-01
Normal-vs-Daily Drinker
7.701600E-01
Normal-vs-Weekly Drinker
4.553600E-01
Normal-vs-Occasional Drinker
3.482000E-02
Normal-vs-Social Drinker
2.968000E-01
Non Drinker-vs-Daily Drinker
1.567430E-01
Non Drinker-vs-Weekly Drinker
8.538000E-01
Non Drinker-vs-Occasional Drinker
1.236210E-01
Non Drinker-vs-Social Drinker
9.651200E-01
Daily Drinker-vs-Weekly Drinker
3.292600E-01
Daily Drinker-vs-Occasional Drinker
3.657700E-03
Daily Drinker-vs-Social Drinker
2.080400E-01
Weekly Drinker-vs-Occasional Drinker
1.344840E-01
Weekly Drinker-vs-Social Drinker
8.925000E-01
Occasional Drinker-vs-Social Drinker
1.153190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.434100E-02
Normal-vs-Grade 2
7.003300E-03
Normal-vs-Grade 3
2.881000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.008640E-01
Grade 1-vs-Grade 3
1.719880E-02
Grade 1-vs-Grade 4
2.434100E-02
Grade 2-vs-Grade 3
2.592400E-01
Grade 2-vs-Grade 4
7.003300E-03
Grade 3-vs-Grade 4
2.881000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.117000E-01
Normal-vs-NonDiabetic
2.692000E-01
Diabetic-vs-NonDiabetic
2.686000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.593000E-01
Normal-vs-NoPancreatitis
3.017800E-01
Pancreatitis-vs-NoPancreatitis
7.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.649950E-01
Normal-vs-N1
3.561000E-01
N0-vs-N1
1.678240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.529900E-02
Normal-vs-TP53-NonMutant
2.212400E-01
TP53-Mutant-vs-TP53-NonMutant
4.078200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
